These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18378338)

  • 21. Clinical course of patients with chronic systolic heart failure due to the association of Chagas disease and systemic arterial hypertension.
    Veiga MF; Rodrigues IF; Cardinalli-Neto A; Otaviano AP; da Rocha BF; Bestetti RB
    Int J Cardiol; 2011 May; 149(1):122-4. PubMed ID: 21345496
    [No Abstract]   [Full Text] [Related]  

  • 22. [Coronary microvascular changes in Chagas' disease].
    Rossi MA; Ramos SG
    Arq Bras Cardiol; 1996 Mar; 66(3):169-72. PubMed ID: 8762698
    [No Abstract]   [Full Text] [Related]  

  • 23. Assessment of quality of life in patients with chronic heart failure secondary to Chagas' cardiomyopathy.
    Dourado KC; Bestetti RB; Cordeiro JA; Theodoropoulos TA
    Int J Cardiol; 2006 Apr; 108(3):412-3. PubMed ID: 16520133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A modified and unifying neurogenic hypothesis can explain the natural history of chronic Chagas heart disease.
    Dávila DF; Donis JH; Torres A; Ferrer JA
    Int J Cardiol; 2004 Aug; 96(2):191-5. PubMed ID: 15262032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional alterations of the autonomic nervous system in Chagas' heart disease.
    Amorim DD; Marin Neto JA
    Sao Paulo Med J; 1995; 113(2):772-84. PubMed ID: 8650476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autonomic nervous system and preventive treatment of ventricular arrhythmias in chagasic disease.
    Gutiérrez O; Garita E; Salazar C
    Int J Cardiol; 2009 Nov; 137(3):291-2. PubMed ID: 18684534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Qualitative changes in the intracardiac autonomic nervous system in chronic Chagas' disease patients].
    Almeida Hde O; Teixeira VP; Gobbi H; Araújo WF
    Arq Bras Cardiol; 1983 Sep; 41(3):171-4. PubMed ID: 6675605
    [No Abstract]   [Full Text] [Related]  

  • 28. Combined renin-angiotensin-aldosterone system inhibition in patients with chronic heart failure secondary to left ventricular systolic dysfunction.
    Gradman AH; Papademetriou V
    Am Heart J; 2009 Jun; 157(6 Suppl):S17-23. PubMed ID: 19450720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac dysautonomia and pathogenesis of Chagas' heart disease.
    Marin-Neto JA
    Int J Cardiol; 1998 Sep; 66(2):129-31. PubMed ID: 9829323
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of right ventricular pacing on patients with Chagas cardiomyopathy with chronic systolic heart failure.
    Parra AV; Bestetti RB; Cardinalli-Neto A; Otaviano AP; Nogueira PR
    Int J Cardiol; 2012 Jan; 154(2):219-20. PubMed ID: 22104987
    [No Abstract]   [Full Text] [Related]  

  • 31. Letter by Rassi et al regarding article, "Beta-blocker therapy and mortality of patients with Chagas cardiomyopathy: a subanalysis of the REMADHE prospective trial".
    Rassi A; Rassi A
    Circ Heart Fail; 2010 May; 3(3):e11; author reply e15. PubMed ID: 20484185
    [No Abstract]   [Full Text] [Related]  

  • 32. Pathogenesis of cardiac neuro-myopathy in Chagas' disease and the role of the autonomic nervous system.
    Iosa D; Dequattro V; Lee DD; Elkayam U; Caeiro T; Palmero H
    J Auton Nerv Syst; 1990 Jul; 30 Suppl():S83-7. PubMed ID: 2212497
    [No Abstract]   [Full Text] [Related]  

  • 33. Cardiac autonomic control mechanisms in Chagas' heart disease. Therapeutic implications.
    Davila DF; Bellabarbra G; Donis JH; Torres A; Rossell OJ; Figueroa O; Amaro M; Vasquez CJ
    Med Hypotheses; 1993 Jan; 40(1):33-7. PubMed ID: 8455464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescription Bias in the Treatment of Chronic Systolic Heart Failure.
    Arfsten H; Goliasch G; Pavo N; Ulmer H; Hülsmann M; Stefenelli T;
    Ann Intern Med; 2020 Jan; 172(1):70-72. PubMed ID: 31569211
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.
    Pascual-Figal DA; Redondo B; Caro C; Manzano S; Garrido IP; Ruipérez JA; Valdés M
    Am J Cardiol; 2008 Dec; 102(12):1711-7. PubMed ID: 19064029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of Levosimendan for myocardiopathy due to acute Chagas' disease.
    de March Ronsoni R; Feijó RV; Melo LH; Schwingel FL; Filho WJ; de Albernaz Muniz RZ; Weber S; Moro A
    Int J Cardiol; 2009 Aug; 136(2):233-5. PubMed ID: 18662834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chagas' heart disease in Europe: an emergent disease?
    Dobarro D; Gomez-Rubin C; Sanchez-Recalde A; Olias F; Bret-Zurita M; Cuesta-Lopez E; Robles-Marhuenda A; Fraile-Vicente JM; Paño-Pardo JR; Lopez-Sendon J
    J Cardiovasc Med (Hagerstown); 2008 Dec; 9(12):1263-7. PubMed ID: 19001935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Predicting heart failure and mortality in chronic Chagas' heart disease. A novel disorder in Spain].
    Acquatella H
    Rev Esp Cardiol; 2008 Feb; 61(2):105-7. PubMed ID: 18364176
    [No Abstract]   [Full Text] [Related]  

  • 39. [Functional study of the circulation in chronic Chagas' heart disease. I].
    Amorim DS; Manço JC; Gallo L
    Arq Bras Cardiol; 1971 Feb; 24(1):43-53. PubMed ID: 5001236
    [No Abstract]   [Full Text] [Related]  

  • 40. [Why is there predominance of right heart failure in Chagas' disease?].
    Marin-Neto JA; Andrade ZA
    Arq Bras Cardiol; 1991 Sep; 57(3):181-3. PubMed ID: 1824192
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.